What is ResMed's forward P/E?

ResMed's forward P/E is 18.79: today's price over the analysts' average EPS estimate for the next twelve months, the earnings expected rather than those reported. By fiscal year, it trades at 19.4 times its FY2027 earnings and 17.8 times its FY2028 earnings.

What is ResMed's PEG ratio?

ResMed's PEG ratio is 2.05: its P/E of 21.41 over the 10.4% a year the analysts expect its earnings per share to grow from FY2026 to FY2030. Around 1 is often read as a P/E in line with the growth; above it, the price asks for more.

ResMed
D
Quotes are delayed by 15 minutes

RMD

Arincen ScoreBeta97/100

97/100B

235.255

USD

-4.06

(-1.69%)

Market Closed

Last updated: 6 Nov, 15:59 GMT-5 · Delayed 15 min

Fair value294.55Plus-20%185Price 235.26478

Q2 FY2027 · Earnings report

EPS estimate 3.03Revenue estimate 1.46B

Q2 FY2027 · Earnings report

Thursday 28 January

EPS estimate 3.03Revenue estimate 1.46B

Fair value294.55Plus-20%185Price 235.26478

Q2 FY2027 · Earnings report

EPS estimate 3.03Revenue estimate 1.46B

Q2 FY2027 · Earnings report

Thursday 28 January

EPS estimate 3.03Revenue estimate 1.46B

Overview Financials Forecast Earnings Dividends Company

ResMed P/E ratio

ResMed's P/E ratio is 21.41: its share price of 235.26 over its earnings per share of 10.99 over the last twelve months.

Today: 21.41
Forward P/E, next 12 months: 18.79
PEG ratio: 2.05
Median, 5 years: 28.59
Low, 5 years: 17.61
High, 5 years: 75.42

P/E ratio = price ÷ EPS (last 12 months) = 235.26 ÷ 10.99 = 21.41

Each day's closing price over the earnings per share of the last four quarters reported by that day (basic EPS, adjusted for splits). The P/E moves with the price every day and with the earnings at each report.

The forward P/E divides the price by the analysts' average EPS estimate for the next twelve months: the fiscal year in progress for the months left in it, the next one for the rest. For past days it uses each year's latest estimate, as the estimates of the time were not recorded (we keep a daily copy from November 2026), so the past line reads the price against the earnings expected by the time each year was reported.

Is ResMed's P/E high compared with its own history?

ResMed's P/E of 21.4 is near the bottom of its 5-year range (17.6 to 75.4, median 28.6). Analysts expect slower growth than in recent years, so the low P/E may be deserved.

5-year range of the daily P/E

Median 28.6

Today 21.4

17.6

75.4

The price against its P/E range

At its 5-year high P/E (75.4)At its median P/E (28.6)At its 5-year low P/E (17.6)Price

Each line is the earnings per share of the day times one P/E of the last five years: the price near the top line is near the most it was paid for those earnings, near the bottom line the least.

Growth a year: the past against what analysts expect

EPSSlower
Expected, to FY2029 11.7%Past 5 years 26.3%Past 3 years 19.5%
RevenueSlower
Expected, to FY2029 5.3%Past 5 years 12.1%Past 3 years 10.2%

	Past 5 years	Past 3 years	Expected, to FY2029	Expected against the past
EPS	26.3%	19.5%	11.7%	Slower
Revenue	12.1%	10.2%	5.3%	Slower

Buyers pay more for each point of growth than usual: a PEG of 1.8 on expected growth against 1.1 on its median P/E and past five years' growth.

What changed in 5 years

Debt is lower than in FY2021: 0.4 times EBITDA against 0.7.
Operating margin is higher than in FY2021: ⁦33.8%⁩ against ⁦28.3%⁩.
Unusual tax: FY2021 at ⁦46.3%⁩ against a usual ⁦19.1%⁩, which moves that year's profit and the P/E readings that include it.
Since 3 January 2022 the price has changed ⁦−9.3%⁩: earnings per share ⁦+219.5%⁩ and the P/E ⁦−71.6%⁩.

Is the price fair? See the whole check

A P/E is compared with the stock's own last five years, not with other companies. Why the market pays more or less (news, rates, the sector) is not in these figures.

P/E ratio by year and by quarter

Fiscal year	Period ending	P/E ratio	Forward P/E	Market cap	Net income
FY2028 · Estimate	30 Jun 2028	17.77	—	—	—
FY2027 · Estimate	30 Jun 2027	19.40	—	—	—
Today		21.41	18.79	33.09B	2.73B
FY2026	30 Jun 2026	18.51	16.07	28.20B	1.52B
FY2025	30 Jun 2025	27.02	23.19	37.85B	1.40B
FY2024	30 Jun 2024	26.92	20.16	27.48B	1.02B
FY2023	30 Jun 2023	35.73	28.85	32.07B	897.56M
FY2022	30 Jun 2022	39.28	32.22	30.62B	779.44M
FY2021	30 Jun 2021	75.49	31.62	35.82B	474.51M
FY2020	30 Jun 2020	44.58	31.62	27.71B	621.67M
FY2019	30 Jun 2019	43.78	27.09	17.71B	404.59M
FY2018	30 Jun 2018	46.86	28.72	14.79B	315.59M
FY2017	30 Jun 2017	32.16	19.78	11.01B	342.28M
FY2016	30 Jun 2016	25.16	22.69	8.87B	352.41M
FY2015	30 Jun 2015	22.44	21.24	7.92B	352.89M
FY2014	30 Jun 2014	20.75	21.23	7.16B	345.27M
FY2013	30 Jun 2013	20.80	19.32	6.39B	307.13M
FY2012	30 Jun 2012	17.86	18.47	4.55B	254.85M
FY2011	30 Jun 2011	20.79	22.93	4.72B	226.99M
FY2010	30 Jun 2010	24.14	26.22	4.59B	190.09M
FY2009	30 Jun 2009	21.03	23.14	3.08B	146.45M
FY2008	30 Jun 2008	25.07	24.48	2.77B	110.30M
FY2007	30 Jun 2007	47.74	25.80	3.17B	66.30M
FY2006	30 Jun 2006	38.49	36.12	3.40B	88.21M
FY2005	30 Jun 2005	34.97	30.00	2.27B	64.79M
FY2004	30 Jun 2004	29.97	23.16	1.72B	57.28M
FY2003	30 Jun 2003	28.33	30.63	1.30B	45.73M
FY2002	30 Jun 2002	23.88	25.37	895.72M	37.51M
FY2001	30 Jun 2001	135.33	55.00	1.57B	11.63M
FY2000	30 Jun 2000	36.30	41.81	806.89M	22.23M
FY1999	30 Jun 1999	30.33	29.64	488.31M	16.10M
FY1998	30 Jun 1998	31.23	47.50	331.07M	10.60M
FY1997	30 Jun 1997	23.73	21.71	177.94M	7.50M
FY1996	30 Jun 1996	25.50	—	114.75M	4.50M
FY1995	30 Jun 1995	18.75	—	52.50M	2.80M
FY1994	30 Jun 1994	29.86	—	35.83M	1.20M
FY1993	30 Jun 1993	40.31	—	32.25M	800.00K

Quarter	Period ending	P/E ratio	Forward P/E	Market cap	Net income
Q1 FY2027	30 Sept 2026	11.57	17.82	31.61B	2.73B
Q4 FY2026	30 Jun 2026	10.59	16.07	28.20B	2.66B
Q3 FY2026	31 Mar 2026	21.64	18.91	32.88B	1.52B
Q2 FY2026	31 Dec 2025	23.74	20.72	35.28B	1.49B
Q1 FY2026	30 Sept 2025	27.88	24.06	40.09B	1.44B
Q4 FY2025	30 Jun 2025	26.98	23.19	37.79B	1.40B
Q3 FY2025	31 Mar 2025	25.01	20.88	32.84B	1.31B
Q2 FY2025	31 Dec 2024	26.90	20.16	33.59B	1.25B
Q1 FY2025	30 Sept 2024	32.22	20.16	35.85B	1.11B
Q4 FY2024	30 Jun 2024	26.90	20.16	27.46B	1.02B
Q3 FY2024	31 Mar 2024	29.03	20.16	27.82B	958.38M
Q2 FY2024	31 Dec 2023	28.43	20.16	25.31B	890.39M
Q1 FY2024	30 Sept 2023	23.99	18.37	21.75B	906.50M
Q4 FY2023	30 Jun 2023	35.79	28.85	32.12B	897.56M
Q3 FY2023	31 Mar 2023	37.28	29.97	32.17B	862.95M
Q2 FY2023	31 Dec 2022	37.72	29.56	30.53B	809.47M
Q1 FY2023	30 Sept 2022	40.65	32.24	31.97B	786.30M
Q4 FY2022	30 Jun 2022	39.36	32.22	30.68B	779.44M
Q3 FY2022	31 Mar 2022	45.50	38.45	35.46B	779.48M
Q2 FY2022	31 Dec 2021	72.85	31.62	38.03B	521.98M
Q1 FY2022	30 Sept 2021	76.83	31.62	38.39B	499.75M
Q4 FY2021	30 Jun 2021	75.64	31.62	35.89B	474.51M
Q3 FY2021	31 Mar 2021	61.67	31.62	28.20B	457.24M
Q2 FY2021	31 Dec 2020	44.18	31.62	30.87B	698.86M
Q1 FY2021	30 Sept 2020	36.54	31.62	24.84B	679.90M
Q4 FY2020	30 Jun 2020	44.72	31.62	27.80B	621.67M
Q3 FY2020	31 Mar 2020	41.56	31.62	21.30B	512.64M
Q2 FY2020	31 Dec 2019	49.13	31.62	22.35B	454.92M
Q1 FY2020	30 Sept 2019	46.34	28.72	19.42B	419.00M
Q4 FY2019	30 Jun 2019	43.88	27.09	17.75B	404.59M
Q3 FY2019	31 Mar 2019	33.66	24.31	15.00B	445.60M
Q2 FY2019	31 Dec 2018	36.14	28.02	16.27B	450.31M
Q1 FY2019	30 Sept 2018	49.02	30.13	16.43B	335.20M
Q4 FY2018	30 Jun 2018	46.87	28.72	14.79B	315.59M
Q3 FY2018	31 Mar 2018	45.78	27.54	14.07B	307.39M
Q2 FY2018	31 Dec 2017	42.40	19.78	12.09B	285.09M
Q1 FY2018	30 Sept 2017	31.07	19.78	10.95B	352.30M
Q4 FY2017	30 Jun 2017	32.31	19.78	11.06B	342.28M
Q3 FY2017	31 Mar 2017	30.56	19.78	10.20B	333.70M
Q2 FY2017	31 Dec 2016	26.23	19.78	8.77B	334.34M
Q1 FY2017	30 Sept 2016	26.20	21.87	9.12B	348.11M
Q4 FY2016	30 Jun 2016	25.22	22.69	8.89B	352.41M
Q3 FY2016	31 Mar 2016	23.37	21.00	8.11B	346.84M
Q2 FY2016	31 Dec 2015	21.50	19.73	7.51B	349.37M
Q1 FY2016	30 Sept 2015	20.43	18.96	7.15B	350.03M
Q4 FY2015	30 Jun 2015	22.49	21.24	7.94B	352.89M
Q3 FY2015	31 Mar 2015	28.62	27.75	10.11B	353.16M
Q2 FY2015	31 Dec 2014	22.29	22.24	7.85B	352.15M
Q1 FY2015	30 Sept 2014	19.86	20.09	6.90B	347.60M
Q4 FY2014	30 Jun 2014	20.61	21.23	7.12B	345.27M
Q3 FY2014	31 Mar 2014	19.06	18.83	6.30B	330.55M
Q2 FY2014	31 Dec 2013	20.57	19.93	6.69B	325.49M
Q1 FY2014	30 Sept 2013	23.68	22.46	7.50B	316.80M
Q4 FY2013	30 Jun 2013	20.76	19.32	6.38B	307.13M
Q3 FY2013	31 Mar 2013	21.36	21.34	6.64B	310.97M
Q2 FY2013	31 Dec 2012	20.48	20.60	5.95B	290.67M
Q1 FY2013	30 Sept 2012	20.90	21.87	5.76B	275.60M
Q4 FY2012	30 Jun 2012	17.48	18.47	4.45B	254.85M
Q3 FY2012	31 Mar 2012	18.83	19.27	4.45B	236.48M
Q2 FY2012	31 Dec 2011	16.51	16.72	3.72B	225.21M
Q1 FY2012	30 Sept 2011	19.61	20.07	4.33B	220.80M
Q4 FY2011	30 Jun 2011	20.81	22.93	4.72B	226.99M
Q3 FY2011	31 Mar 2011	20.63	23.03	4.57B	221.68M
Q2 FY2011	31 Dec 2010	24.31	27.58	5.28B	217.16M
Q1 FY2011	30 Sept 2010	24.28	27.16	4.97B	204.69M
Q4 FY2010	30 Jun 2010	24.23	26.22	4.61B	190.09M
Q3 FY2010	31 Mar 2010	26.34	29.19	4.80B	182.29M
Q2 FY2010	31 Dec 2009	22.75	25.60	3.93B	172.65M
Q1 FY2010	30 Sept 2009	21.23	23.78	3.41B	160.52M
Q4 FY2009	30 Jun 2009	20.95	23.14	3.07B	146.45M
Q3 FY2009	31 Mar 2009	20.50	20.97	2.68B	130.71M
Q2 FY2009	31 Dec 2008	23.42	23.26	2.84B	121.20M
Q1 FY2009	30 Sept 2008	28.47	28.00	3.25B	114.20M
Q4 FY2008	30 Jun 2008	24.50	24.48	2.70B	110.30M
Q3 FY2008	31 Mar 2008	30.18	28.22	3.27B	108.34M
Q2 FY2008	31 Dec 2007	64.29	34.34	4.07B	63.29M
Q1 FY2008	30 Sept 2007	50.79	27.38	3.32B	65.43M
Q4 FY2007	30 Jun 2007	48.26	25.80	3.20B	66.30M
Q3 FY2007	31 Mar 2007	62.88	33.05	3.88B	61.72M
Q2 FY2007	31 Dec 2006	36.33	33.95	3.76B	103.45M
Q1 FY2007	30 Sept 2006	31.58	29.28	3.06B	96.77M
Q4 FY2006	30 Jun 2006	40.19	36.12	3.55B	88.21M
Q3 FY2006	31 Mar 2006	39.54	35.18	3.19B	80.70M
Q2 FY2006	31 Dec 2005	37.64	31.93	2.72B	72.21M
Q1 FY2006	30 Sept 2005	41.63	34.61	2.80B	67.30M
Q4 FY2005	30 Jun 2005	35.56	30.00	2.30B	64.79M
Q3 FY2005	31 Mar 2005	29.89	23.16	1.94B	65.06M
Q2 FY2005	31 Dec 2004	27.95	23.16	1.74B	62.21M
Q1 FY2005	30 Sept 2004	27.36	23.16	1.61B	58.96M
Q4 FY2004	30 Jun 2004	30.09	23.16	1.72B	57.28M
Q3 FY2004	31 Mar 2004	27.67	22.94	1.52B	54.95M
Q2 FY2004	31 Dec 2003	26.79	23.84	1.40B	52.17M
Q1 FY2004	30 Sept 2003	30.59	29.15	1.48B	48.41M
Q4 FY2003	30 Jun 2003	28.52	30.63	1.30B	45.73M
Q3 FY2003	31 Mar 2003	25.18	25.60	1.06B	42.02M
Q2 FY2003	31 Dec 2002	25.12	25.04	1.01B	40.14M
Q1 FY2003	30 Sept 2002	24.40	24.03	940.43M	38.54M
Q4 FY2002	30 Jun 2002	24.29	25.37	910.92M	37.51M
Q3 FY2002	31 Mar 2002	35.68	36.53	1.29B	36.04M
Q2 FY2002	31 Dec 2001	111.69	51.80	1.73B	15.47M
Q1 FY2002	30 Sept 2001	120.18	51.88	1.63B	13.59M
Q4 FY2001	30 Jun 2001	136.62	55.00	1.59B	11.63M
Q3 FY2001	31 Mar 2001	133.23	47.56	1.26B	9.48M
Q2 FY2001	31 Dec 2000	48.53	51.15	1.24B	25.50M
Q1 FY2001	30 Sept 2000	40.09	44.01	962.50M	24.01M
Q4 FY2000	30 Jun 2000	35.94	41.81	798.73M	22.23M
Q3 FY2000	31 Mar 2000	53.13	57.54	1.10B	20.64M
Q2 FY2000	31 Dec 1999	32.63	34.79	626.40M	19.20M
Q1 FY2000	30 Sept 1999	27.78	28.55	491.67M	17.70M
Q4 FY1999	30 Jun 1999	30.11	29.64	484.76M	16.10M
Q3 FY1999	31 Mar 1999	28.56	29.40	414.19M	14.50M
Q2 FY1999	31 Dec 1998	47.50	56.51	631.80M	13.30M
Q1 FY1999	30 Sept 1998	32.60	40.54	378.18M	11.60M
Q4 FY1998	30 Jun 1998	31.29	47.50	331.64M	10.60M
Q3 FY1998	31 Mar 1998	25.80	35.52	250.25M	9.70M
Q2 FY1998	31 Dec 1997	24.10	27.09	202.40M	8.40M
Q1 FY1998	30 Sept 1997	22.70	24.16	179.30M	7.90M
Q4 FY1997	30 Jun 1997	22.29	21.71	167.20M	7.50M
Q3 FY1997	31 Mar 1997	17.15	—	118.34M	6.90M
Q2 FY1997	31 Dec 1996	25.23	—	156.40M	6.20M
Q1 FY1997	30 Sept 1996	23.43	—	126.51M	5.40M
Q4 FY1996	30 Jun 1996	23.31	—	104.91M	4.50M
Q3 FY1996	31 Mar 1996	22.70	—	84.00M	3.70M
Q2 FY1996	31 Dec 1995	15.90	—	50.87M	3.20M
Q1 FY1996	30 Sept 1995	23.16	—	69.49M	3.00M
Q4 FY1995	30 Jun 1995	18.75	—	52.50M	2.80M
Q3 FY1995	31 Mar 1995	19.60	—	47.03M	2.40M
Q2 FY1995	31 Dec 1994	23.52	—	47.03M	2.00M
Q1 FY1995	30 Sept 1994	29.39	—	47.03M	1.60M
Q4 FY1994	30 Jun 1994	32.16	—	38.59M	1.20M
Q3 FY1994	31 Mar 1994	36.65	—	40.31M	1.10M
Q2 FY1994	31 Dec 1993	40.31	—	40.31M	1.00M
Q1 FY1994	30 Sept 1993	44.79	—	40.31M	900.00K
Q4 FY1993	30 Jun 1993	44.79	—	35.83M	800.00K
Q3 FY1993	31 Mar 1993	—	—	35.83M	—
Q2 FY1993	31 Dec 1992	—	—	42.08M	—
Q1 FY1993	30 Sept 1992	—	—	42.08M	—

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters. A forecast year's P/E is today's price over the analysts' EPS estimate for that year.

Common questions about ResMed's P/E ratio

Source: Financial Modeling Prep

ResMed
D
Quotes are delayed by 15 minutes

RMD

ResMed P/E ratio

Is ResMed's P/E high compared with its own history?

The price against its P/E range

Growth a year: the past against what analysts expect

What changed in 5 years

P/E ratio by year and by quarter

Common questions about ResMed's P/E ratio

What is ResMed's P/E ratio?

Is ResMed's P/E ratio high or low?

What is ResMed's forward P/E?

What is ResMed's PEG ratio?

Need help?

ResMed DQuotes are delayed by 15 minutes

RMD

ResMed P/E ratio

Is ResMed's P/E high compared with its own history?

P/E ratio by year and by quarter

Common questions about ResMed's P/E ratio

What is ResMed's P/E ratio?

Is ResMed's P/E ratio high or low?

What is ResMed's forward P/E?

What is ResMed's PEG ratio?

Need help?

ResMed
D
Quotes are delayed by 15 minutes